UNILABS LABORATORIEMEDISIN AS

Operating

Oppfylle inngåtte avtaler med lokale og regionale helseforetak om å yte laboratoriemedisinsk service, foruten å drive ordinær laboratorievirksomhet og annen virksomhet i tilknytning til dette.

Å ha laboratoriemedisinsk service foruten å drive ordinær laboratorievirksomhet, drift av fast eiendom, omsetning av varer og tjenester, herunder sentralbordtjenester, edb-tjenester, renholdstjenester, datautstyr og kontorrekvisita, samt annen virksomhet i naturlig tilknytning til dette.

Organization

CEO: KK
Kjetil Kollstad1973
Chairman of the board: KK
Kjetil Kollstad1973
Years since formation: 31 years; since Feb 19, 1995
Type: Limited company
VAT registered: Yes
Number of employees: 12

Ownership

Number of shares and share classes: 358; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2025: 88,985,071; NOK
Annual total result 2025: -11,561,799; NOK
Total equity 2025: 28,970,883; NOK

Last update: Aug 19, 2026

Management

Management / administration

Name	Role	Shares
KK Kjetil Kollstad 1973	Managing Director/CEO	-

Board

Name	Role	Shares
KK Kjetil Kollstad 1973	Chairman	-
FH Fredrik Hoff Eriksen 1986	Board Member	-
MY Mikaela Ywonne Mars 1980	Board Member	-

Others

Name	Role	Shares
P PRICEWATERHOUSECOOPERS AS	Auditor	-

Last update: Nov 19, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
U UNILABS NORGE AS	Ordinary shares	358	100 %

Last update: Sep 25, 2026

Group structure

UNILABS NORGE AS
Total operating income 2025: NOK 660,253,563
Operating profit 2025: NOK 108,098,961
Employees: 284

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	88,985,071	204,995,171	159,671,947	153,502,604	173,548,725
Annual Total Result	-11,561,799	11,006,474	1,569,766	3,407,614	7,152,613
Total assets	62,518,249	132,117,350	109,499,213	113,991,398	135,947,263
Total liabilities	21,985,567	83,680,531	72,068,868	78,130,818	103,494,297
Total equity	28,970,883	48,436,819	37,430,346	35,860,580	32,452,966

P&L

Year	2025	2024	2023	2022	2021
Total operating income	88,985,071	204,995,171	159,671,947	153,502,604	173,548,725
Total operating costs	103,565,902	189,561,781	155,902,472	146,574,041	162,832,939
Operating result	-14,580,831	15,433,390	3,769,475	6,928,563	10,715,786
Financial income/costs	-310,417	-1,661,236	-1,880,455	-2,723,209	-1,647,358
Profit before tax	-14,891,248	13,772,155	1,889,020	4,205,354	9,068,428
Total tax & extraordinary income/cost	-3,329,449	2,765,681	319,254	797,740	1,915,815
Annual Total Result	-11,561,799	11,006,474	1,569,766	3,407,614	7,152,613

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	16,621,116	61,099,620	67,958,390	68,434,337	75,083,828
Total current assets	45,897,134	71,017,730	41,540,824	45,557,062	60,863,434
Total assets	62,518,249	132,117,350	109,499,213	113,991,398	135,947,263
Short term debt	16,001,388	54,799,144	41,285,400	41,896,617	47,495,616
Long term debt	5,984,179	28,881,386	30,783,468	36,234,202	55,998,681
Total liabilities	21,985,567	83,680,531	72,068,868	78,130,818	103,494,297
Contributed capital	15,402,665	11,745,003	11,745,003	11,745,003	11,745,003
Retained earnings	13,568,219	36,691,817	25,685,343	24,115,577	20,707,963
Total equity	28,970,883	48,436,819	37,430,346	35,860,580	32,452,966
Total equity and liabilities	50,956,450	132,117,350	109,499,213	113,991,398	135,947,263

Classification

21st company classification

BETA

Industrial large enterprise

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

UNILABS LABORATORIEMEDISIN AS935 439 035